Literature DB >> 14762794

Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation.

Steven Gallinger1, Melyssa Aronson, Katayoon Shayan, Elyanne M Ratcliffe, Justin T Gerstle, Patricia C Parkin, Heidi Rothenmund, Marina Croitoru, Ewa Baumann, Peter R Durie, Rosanna Weksberg, Aaron Pollett, Robert H Riddell, Bo Y Ngan, Ernest Cutz, Alain E Lagarde, Helen S L Chan.   

Abstract

Heterozygous germline DNA mismatch repair gene mutations are typically associated with hereditary nonpolyposis colorectal cancer. The molecular hallmark of this syndrome is high-frequency microsatellite instability in the tumors. Rare childhood cases with homozygous or compound heterozygous DNA mismatch repair gene mutations have a described predisposition to leukemia, lymphoma, and brain tumors but not to gastrointestinal cancer. We have now characterized a family in which 2 children with a homozygous germline DNA mismatch repair gene mutation developed early-onset gastrointestinal cancers. The 11-year-old proband had café-au-lait macules and developed metastatic duodenal adenocarcinoma that arose in a tubulovillous adenoma. His 9-year-old sister with café-au-lait macules and axillary freckling presented with malignant colon polyps. A 6-year-old sister with café-au-lait macules, hairy nevi, and a plexiform neurofibroma of the tongue has no malignancies to date. The family history did not fulfill the Amsterdam criteria for hereditary nonpolyposis colorectal cancer, but 2 relatives in their 60s had gastric cancer and colorectal cancer, whereas the parents, who are first cousins, remain cancer free. The proband's metastatic duodenal cancer and his sister's malignant colon polyps had high-frequency microsatellite instability but had detectable MLH1, MSH2, and MSH6 proteins by immunohistochemistry. Because some germline DNA mismatch repair gene deficiencies are associated with apparently intact immunohistochemical DNA mismatch repair gene expression in tumors, we proceeded to DNA sequencing, which showed that all 3 children had a germline homozygous MLH1 missense mutation (exon 18, codon 687, CGG-->TGG), whereas both parents were heterozygous for this mutation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762794     DOI: 10.1053/j.gastro.2003.11.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.

Authors:  W Stewart; J P Traynor; A Cooke; S Griffiths; N F Onen; M Balsitis; A A Shah; M Upadhyaya; E S Tobias
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

2.  RAS signaling pathways, mutations and their role in colorectal cancer.

Authors:  Kypros Zenonos; Katy Kyprianou
Journal:  World J Gastrointest Oncol       Date:  2013-05-15

3.  Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.

Authors:  Lise Lotte Christensen; Reetta Kariola; Mari K Korhonen; Friedrik P Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten A Brandt; Inge Bernstein; Thomas V O Hansen; Rikke Hagemann-Madsen; Claus L Andersen; Minna Nyström; Torben F Ørntoft
Journal:  Fam Cancer       Date:  2009-08-21       Impact factor: 2.375

Review 4.  Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations.

Authors:  Prathap Bandipalliam
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Predictive genetic testing in children: constitutional mismatch repair deficiency cancer predisposing syndrome.

Authors:  Zandrè Bruwer; Ursula Algar; Alvera Vorster; Karen Fieggen; Alan Davidson; Paul Goldberg; Helen Wainwright; Rajkumar Ramesar
Journal:  J Genet Couns       Date:  2013-10-15       Impact factor: 2.537

Review 6.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

7.  The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Authors:  Juana V Martín-López; Ysamar Barrios; Vicente Medina-Arana; Miguel Andújar; Sanghee Lee; Liya Gu; Guo-Min Li; Josef Rüschoff; Eduardo Salido; Richard Fishel
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

Review 8.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

9.  Microsatellite instability in the peripheral blood leukocytes of HNPCC patients.

Authors:  Mary I Coolbaugh-Murphy; Jing-Ping Xu; Louis S Ramagli; Brian C Ramagli; Barry W Brown; Patrick M Lynch; Stanley R Hamilton; Marsha L Frazier; Michael J Siciliano
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

10.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.